
Cellular Growth  Tech to translate  Making it
Leonardo Royal Hotel London Tower Bridge
20 October 2022
Advanced Therapies Integrates Speakers 2022

MATTHEW DURDY
Chief Executive Officer
Cell and Gene Therapy Catapult

MARTIN MURPHY
Chief Executive Officer
Syncona Investment Management

JASON MELLAD
Chief Executive Officer
Start Codon

SHARON BROWNLOW
Chief Business Officer
Cell & Gene Therapy Catapult

JOE HEALEY
Chief Executive Officer and
Co-Founder
NanoSyrinx

FRANCESCA GLIUBICH
Director
London Advanced Therapies

SAM GOLDSMITH
Senior Commercialisation of Research Manager
Cell and Gene Therapy Catapult

ERIC HALIOUA
President & Chief Executive Officer
PDC*line Pharma

JAMES KUSENA
Vice President of Bioprocessing and Applications
MicrofluidX

LEE DUNHAM
Head of Collaboration
Cell and Gene Therapy Catapult

MIGUEL FORTE
Chief Executive Officer
Bone Therapeutics

JENNY LAIRD
Vice President, Search & Evaluation Pain & Neurodegeneration
Eli Lilly and Company

MOIN SALEEM
Professor of Paediatric Renal Medicine
University of Bristol

RAJ MEHTA
Entrepreneur in Residence
Apple Tree Partners

TERRI GASKELL
Chief Technical Officer
Rinri Therapeutics Ltd

NATHAN SIGWORTH
Co-founder and Chief Executive Officer
CCX

KERSTIN PAPENFUSS
Associate Director Therapeutics
Deep Science Ventures

STEFANOS THEOHARIS
Independent Expert
Former Bone Therapeutics SA

NICK STEPHENS
Executive Chairman
The RSA Group

WILLIAM (BILL) SCOTT
Scientific Director, Transplant Regenerative Medicine
Newcastle University Medical School

SIMON CHANDLER
Chief Executive Officer
Rinri Therapeutics

FLIC GABBAY
Founding & Senior Partner
tranScrip

KIRSTY WYDENBACH
Head of Regulatory Strategy
Weatherden

LEE CONEY
Head of Non-Clinical Safety
Cell and Gene Therapy Catapult

MUSTAFA MUNYE
Director of R&D Operations
Complement Therapeutics

MARCELO BRAVO
Co Founder & Chief Executive Officer
OXVax

ANTOINE ESPINET
Co Founder & Chief Executive Officer
MicrofluidX

FREDDIE DEAR
Head of Corporate Development & Portfolio Manager
Ascend Gene & Cell Therapies

ANGELA OSBORNE
Chief Executive Officer
eXmoor pharma concepts

DOMINIC SCHMIDT
General Partner
Advent Life Sciences

IAN ANDERSON
Global Senior Principal Scientist, Global Biologics
Lonza

CHRIS BAKER
Investment Principal
LifeArc Ventures

OLIVER SEXTON
Investment Director
UKI2S

GAURAV VENKATARAMAN
Cofounder and Chief Executive Officer
Trisk Bio

PANOS KEFALAS
Director of the Access Strategy Group
Cell and Gene Therapy Catapult

BRIAN MULLAN
Chief Technical Officer
Cell and Gene Therapies, Yposkesi

NEELAM PANCHAL
Senior Commercialisation of Research Scientist
Cell and Gene Therapy Catapult

AGATHE GUILLOT
Senior Regulatory Consultant
DLRC

CATRIONA CROMBIE
Associate Director: Technology Transfer and Philanthropic Fund Manager
LifeArc

KWOK PANG
COO and Co-Founder
Autolomous

JOHN LIDDELL
Chief Technologist
CPI Biologics

NICOLA REDFERN
Consultant
NJ Redfern Ltd

PAUL CATCHPOLE
Value & Access Policy Director
ABPI

JIMMY MCBLANE
Preclinical Assessor
MHRA

STEVE KAPPENTHULER
Chief Business Officer and Co-founder
Muvon Therapeutics

VERITY NANCOLLIS
Associate Director BDM&C
Pharmaron

JESÚS ZURDO
Global Head Cell, Gene Therapy & Bioproduction
Horizon Discovery

MICHAEL BAKER
Senior Director, Viral Gene Therapy
FUJIFILM Diosynth Biotechnologies

RUI SOUSA
Co-founder and CEO
Stemmatters

DAVID GRIFFITHS-JOHNSON
Head of Manufacturing
Office for Life Sciences

LAURA BESWICK
Head of Health Economics and Market Access
Cell and Gene Therapy Catapult

JAMES FRY
Partner and Head of Life Sciences
Mills & Reeve

RAJA SHARIF
Founder and Chief Executive Officer
ATMPS Ltd

LEN PATTENDEN
Chief Operating Officer
Ascend GCTx Ltd

ANDREEA IFTIMIA-MANDER
Director of Lifesciences
Biomatics

ANDREA CUSACK
CEO & Managing Director
leon-nanodrugs

FRASER McBLANE
Global Project Team Lead
Novartis

KAROLINA ZAPADKA
Investor
Parkwalk Advisors

ANDY LEWIN
Chief Business Officer
Ascend Gene and Cell Therapies

Cellular Growth | Tech to translate | Making it